Information | NCP Flanders

EIT Urban Mobility

The EIT Urban Mobility is one of the younger innovation communities and only started in 2019. Its mission is to create more liveable urban spaces, improve quality of life in the cities and decarbonize the mobility

Community and Programmes overview

EIT Urban Mobility is a knowledge and innovation community (KIC) that is focused on transforming urban mobility systems to make them more sustainable, efficient, and people-centric. It brings together a wide range of stakeholders (including businesses, cities, universities, research centers, and other organizations) to collaborate and drive innovation in urban mobility.

The EIT Urban Mobility executes four main activities:

Match and connect public and private sector entities from across the knowledge triangle (including students, research institutes, universities, large enterprises, SMEs, startups, NGOs and the public sector) to develop and pilot innovative solutions throughout all our activities and geographies.
Educating and transforming talent into urban mobility professionals and entrepreneurs
Helping innovations reach the market through these initiatives
- strategic innovation call for public and private actors who want to pilot and scale up new solutions that tackle the most pressing urban mobility challenges.
- SME market expansion call offers these companies the opportunity to pilot their products or services with an end-client
- City Rapid Applications for Transport (RAPTOR) is a city-driven, challenge-based, agile innovation programme where startups and SMEs compete to provide the most innovative, feasible and impactful mobility solutions to an urban challenge
- Business RAPTOR is the venture client programme, designed to address challenges faced by companies in a rapidly evolving technological landscape
- Innovation advisory service facilitates matchmaking for cities, public transport authorities and industry with the latest technological innovations for sustainable urban mobility solutions
- Horizon Lab helps public and private partners to prepare for Horizon Europe projects
- Mobility innovation marketplace connects public and private organisations with existing market solutions
Making start-ups and scale-ups grow according to their full potential. More in particular they can
- Gain access to funding through grants and equity investments
- Upskill via partner-led programmes
- Become part of an extensive and dedicated pan-European mobility ecosystem

How to get involved?

The EIT publishes regularly calls for proposals for these different programmes. You can find out the opportunities and latest news at the EIT Urban Mobility webpage.

The headquarter of this innovation community is in Barcelona but there is a regional hub in Amsterdam which serves as a point of contact for interested parties from Flanders (west@eiturbanmobility.eu). You can also email the National Contact Point (NCP) via pascal.verheye@vlaio.be

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

How to use partnerships?

orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.

networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.

ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.

steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

NCP Flanders

Updates

Funding programmes

About NCP Flanders

Content

Tools